Jump to main content
Jump to site search

Issue 23, 2018
Previous Article Next Article

Oncosis-inducing cyclometalated iridium(III) complexes

Author affiliations

Abstract

Oncosis is a non-apoptotic form of programmed cell death (PCD), which differs from apoptosis in both morphological changes and inner pathways, and might hold the key to defeating a major obstacle in cancer therapy – drug-resistance, which is often a result of the intrinsic apoptosis resistance of tumours. However, despite the fact that the term “oncosis” was coined and used much earlier than apoptosis, little effort has been made to discover new drugs which can initiate this form of cell death, in comparison to drugs inducing apoptosis or any other type of PCD. So herein, we present the synthesis of a series of mitochondria-targeting cyclometalated Ir(III) complexes, which activated the oncosis-specific protein porimin and calpain in cisplatin-resistant cell line A549R, and determined their cytotoxicity against a wide range of drug-resistant cancer types. To the best of our knowledge, these complexes are the very first metallo-components to induce oncosis in drug-resistant cancer cells.

Graphical abstract: Oncosis-inducing cyclometalated iridium(iii) complexes

Back to tab navigation

Supplementary files

Publication details

The article was received on 11 Mar 2018, accepted on 02 May 2018 and first published on 03 May 2018


Article type: Edge Article
DOI: 10.1039/C8SC01142G
Citation: Chem. Sci., 2018,9, 5183-5190
  • Open access: Creative Commons BY-NC license
  •   Request permissions

    Oncosis-inducing cyclometalated iridium(III) complexes

    R. Guan, Y. Chen, L. Zeng, T. W. Rees, C. Jin, J. Huang, Z. Chen, L. Ji and H. Chao, Chem. Sci., 2018, 9, 5183
    DOI: 10.1039/C8SC01142G

    This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material and it is not used for commercial purposes.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements